{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:22:31Z","timestamp":1770524551851,"version":"3.49.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Chemotherapy-induced peripheral neuropathy (CIPN) is a shared burden for 68.1% of oncological patients undergoing chemotherapy with Paclitaxel (PTX). The symptoms are intense and troublesome, patients reporting paresthesia, loss of sensation, and dysesthetic pain. While current medications focus on decreasing the symptom intensity, often ineffective, no medication is yet recommended by the guidelines for the prevention of CIPN. Cannabinoids are an attractive option, as their neuroprotective features have already been demonstrated in neuropathies with other etiologies, by offering the peripheral neurons protection against toxic effects, which promotes analgesia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We aim to screen several new cannabinoids for their potential use as neuroprotective agents for CIPN by investigating the cellular toxicity profile and by assessing the potential neuroprotective features against PTX using a primary dorsal root ganglion neuronal culture.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our study showed that synthetic cannabinoids JWH-007, AM-694 and MAB-CHMINACA and phytocannabinoids Cannabixir<jats:sup>\u00ae<\/jats:sup> Medium dried flowers (NC1) and Cannabixir<jats:sup>\u00ae<\/jats:sup> THC full extract (NC2) preserve the viability of fibroblasts and primary cultured neurons, in most of the tested dosages and time-points. The combination between the cannabinoids and PTX conducted to a cell viability of 70%\u201389% compared to 40% when PTX was administered alone for 48\u00a0h. When assessing the efficacy for neuroprotection, the combination between cannabinoids and PTX led to better preservation of neurite length at all tested time-points compared to controls, highly drug and exposure-time dependent. By comparison, the combination of the cannabinoids and PTX administered for 24\u00a0h conducted to axonal shortening between 23% and 44%, as opposed to PTX only, which shortened the axons by 63% compared to their baseline values.<\/jats:p><jats:p><jats:bold>Discussion and Conclusion:<\/jats:bold> Cannabinoids could be potential new candidates for the treatment of paclitaxel-induced peripheral neuropathy; however, our findings need to be followed by additional tests to understand the exact mechanism of action, which would support the translation of the cannabinoids in the oncological clinical practice.<\/jats:p>","DOI":"10.3389\/fphar.2024.1395951","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:27:01Z","timestamp":1718166421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth"],"prefix":"10.3389","volume":"15","author":[{"given":"Ioana","family":"Creanga-Murariu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leontina-Elena","family":"Filipiuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Raluca","family":"Gogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitica","family":"Ciorpac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Marinela","family":"Cumpat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan-Ionel","family":"Tamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Alexa-Stratulat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/brain\/awab113","article-title":"Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7","volume":"144","author":"Akin","year":"2021","journal-title":"Brain"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-62703-640-5","volume-title":"Neuronal cell culture","author":"Amini","year":"2013"},{"key":"B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.irn.2019.06.012","article-title":"Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders","volume":"146","author":"Antonazzo","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1126\/science.291.5513.2530","article-title":"Neurobiology. How cannabinoids work in the brain","volume":"291","author":"Barinaga","year":"2001","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14728222.2017.1328057","article-title":"Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain","volume":"21","author":"Berta","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"B7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s40265-019-01132-x","article-title":"Cannabinoids: current and future options to treat chronic and chemotherapy-induced neuropathic pain","volume":"79","author":"Blanton","year":"2019","journal-title":"Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.nurt.2009.07.001","article-title":"Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain","volume":"6","author":"Bordet","year":"2009","journal-title":"Neurotherapeutics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J. Clin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"785176","DOI":"10.3389\/fphys.2021.785176","article-title":"Cannabinoid therapeutics in chronic neuropathic pain: from animal research to human treatment","volume":"12","author":"Campos","year":"2021","journal-title":"Front. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clbc.2011.03.006","article-title":"Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach","volume":"11","author":"Carlson","year":"2011","journal-title":"Clin. Breast Cancer"},{"key":"B13","first-page":"389","article-title":"Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration","volume":"21","author":"Cavaletti","year":"2000","journal-title":"Neurotoxicology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/01.res.87.4.323","article-title":"Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1","volume":"87","author":"Chen","year":"2000","journal-title":"Circ. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1139\/y76-075","article-title":"Toxicity testing in vitro. I. The effects of delta 9-tetrahydrocannabinol and aflatoxin B1 on the growth of cultured human fibroblasts","volume":"54","author":"Cooper","year":"1976","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1211506","DOI":"10.3389\/fphar.2023.1211506","article-title":"Should oncologists trust cannabinoids?","volume":"14","author":"Creanga-Murariu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/plants10091834","article-title":"Shape matters: plant architecture affects chemical uniformity in large-size medical cannabis plants","volume":"10","author":"Danziger","year":"2021","journal-title":"Plants"},{"key":"B18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1124\/mol.115.098483","article-title":"CB1 knockout mice unveil sustained CB2-mediated antiallodynic effects of the mixed CB1\/CB2 agonist CP55,940 in a mouse model of paclitaxel-induced neuropathic pain","volume":"88","author":"Deng","year":"","journal-title":"Mol. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal","volume":"77","author":"Deng","year":"","journal-title":"Biol. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"112671","DOI":"10.1016\/j.biopha.2022.112671","article-title":"Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update","volume":"147","author":"Desforges","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42238-022-00142-z","article-title":"Medical cannabis regulation: an overview of models around the world with emphasis on the Brazilian scenario","volume":"4","author":"de Souza","year":"2022","journal-title":"J. Cannabis Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/biom12121873","article-title":"Palmitoylethanolamide mitigates paclitaxel toxicity in primary dorsal root ganglion neurons","volume":"12","author":"Elfarnawany","year":"2022","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/toxics11070581","article-title":"Time- and concentration-dependent adverse effects of paclitaxel on non-neuronal cells in rat primary dorsal root ganglia","volume":"11","author":"Elfarnawany","year":"2023","journal-title":"Toxics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","article-title":"Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats","volume":"60","author":"Fern\u00e1ndez-L\u00f3pez","year":"2006","journal-title":"Pediatr. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/pharmaceutics13111823","article-title":"Major phytocannabinoids and their related compounds: should we only search for drugs that act on cannabinoid receptors?","volume":"13","author":"Filipiuc","year":"2021","journal-title":"Pharmaceutics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2174\/138161208785740117","article-title":"Mechanisms of control of neuron survival by the endocannabinoid system","volume":"14","author":"Galve-Roperh","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","article-title":"The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions","author":"Gornstein","year":"2014","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/biom11050766","article-title":"Can cannabidiol affect the efficacy of chemotherapy and epigenetic treatments in cancer?","volume":"11","author":"Griffiths","year":"2021","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/toxsci\/kfw254","article-title":"Editor\u2019s highlight: multiparametric image analysis of rat dorsal root ganglion cultures to evaluate peripheral neuropathy-inducing chemotherapeutics","volume":"156","author":"Guo","year":"2017","journal-title":"Toxicol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bjp.0705465","article-title":"Neurons on cannabinoids: dead or alive?","volume":"140","author":"Guzman","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","article-title":"Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy","volume":"33","author":"Hausheer","year":"2006","journal-title":"Semin. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB(1) cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000499599","article-title":"Prevention and management of chemotherapy-induced polyneuropathy","volume":"14","author":"Jordan","year":"2019","journal-title":"Breast Care (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/FBP.0b013e3283474a6d","article-title":"CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain","volume":"22","author":"Khasabova","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1523\/JNEUROSCI.0403-12.2012","article-title":"Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy","volume":"32","author":"Khasabova","year":"2012","journal-title":"J. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1074\/jbc.M106802200","article-title":"Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore","volume":"277","author":"Kidd","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.3390\/molecules26196077","article-title":"In vitro studies on therapeutic effects of cannabidiol in neural cells: neurons, glia, and neural stem cells","volume":"26","author":"Kim","year":"2021","journal-title":"Molecules"},{"key":"B44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/toxics9100229","article-title":"Pathomechanisms of paclitaxel-induced peripheral neuropathy","volume":"9","author":"Klein","year":"2021","journal-title":"Toxics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3389\/fphar.2018.00889","article-title":"Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer","volume":"9","author":"Kosgodage","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1111\/pme.12413","article-title":"The role of the dorsal root ganglion in the development of neuropathic pain","volume":"15","author":"Krames","year":"2014","journal-title":"Pain Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0006-8993(00)02739-6","article-title":"Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2","volume":"877","author":"Lawston","year":"2000","journal-title":"Brain Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"113140","DOI":"10.1016\/j.expneurol.2019.113140","article-title":"Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: prospects and limitations","volume":"326","author":"Lehmann","year":"2020","journal-title":"Exp. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J. Pain Symptom Manage"},{"key":"B51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0163-7258(84)90025-1","article-title":"Taxol: an antimitotic agent with a new mechanism of action","volume":"25","author":"Manfredi","year":"1984","journal-title":"Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0203793","DOI":"10.1371\/journal.pone.0203793","article-title":"Euthanasia of laboratory mice: are isoflurane and sevoflurane real alternatives to carbon dioxide?","volume":"13","author":"Marquardt","year":"2018","journal-title":"PLoS ONE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5234943","DOI":"10.1155\/2018\/5234943","article-title":"Targeting the endocannabinoid system for prevention or treatment of chemotherapy-induced neuropathic pain: studies in animal models","volume":"2018","author":"Masocha","year":"2018","journal-title":"Pain Res. Manag."},{"key":"B54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s1471-4914(02)02276-1","article-title":"Cannabinoids and brain injury: therapeutic implications","volume":"8","author":"Mechoulam","year":"2002","journal-title":"Trends Mol. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-x","article-title":"Hashish. I. The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron."},{"key":"B56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jss.2008.06.045","article-title":"Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines","volume":"155","author":"Miyato","year":"2009","journal-title":"J. Surg. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-2990.2012.01295.x","article-title":"Two distinct types of dying back axonal degeneration in vitro","volume":"39","author":"\u00d6zt\u00fcrk","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease--successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"114520","DOI":"10.1016\/j.bcp.2021.114520","article-title":"Usefulness of the measurement of neurite outgrowth of primary sensory neurons to study cancer-related painful complications","volume":"188","author":"Park","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B61","first-page":"A186","article-title":"Using imagej to assess neurite outgrowth in mammalian cell cultures: research data quantification exercises in undergraduate neuroscience lab","volume":"16","author":"Pemberton","year":"2018","journal-title":"J. Undergrad. Neurosci. Educ."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","article-title":"Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/s0165-6147(00)01482-6","article-title":"The endocannabinoid system as a target for therapeutic drugs","volume":"21","author":"Piomelli","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1744-8069-10-27","article-title":"Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery","volume":"10","author":"Rahn","year":"2014","journal-title":"Mol. Pain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.bjp.0707333","article-title":"Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats","volume":"152","author":"Rahn","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-017-0693-1","article-title":"Cannabis and cannabinoids for chronic pain","volume":"19","author":"Romero-Sandoval","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fncel.2019.00566","article-title":"Neuroprotective effect of AM404 against NMDA-induced hippocampal excitotoxicity","volume":"13","author":"Saliba","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.mehy.2004.02.043","article-title":"Are cannabinoid drugs neurotoxic or neuroprotective?","volume":"63","author":"Sarne","year":"2004","journal-title":"Med. Hypotheses"},{"key":"B70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2174\/156800705774933005","article-title":"Cannabinoids: between neuroprotection and neurotoxicity","volume":"4","author":"Sarne","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model","volume":"13","author":"Scott","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B72","first-page":"1065","article-title":"Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells","volume":"26","author":"Scuteri","year":"2006","journal-title":"Anticancer Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.5935\/1806-0013.20160043","article-title":"Experimental models for the study of neuropathic pain","volume":"17","author":"Sousa","year":"2016","journal-title":"Rev. dor"},{"key":"B75","doi-asserted-by":"publisher","first-page":"113121","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: a current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/medicina56010024","article-title":"Challenges and opportunities in preclinical research of synthetic cannabinoids for pain therapy","volume":"56","author":"Tamba","year":"2020","journal-title":"Med. Kaunas."},{"key":"B77","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3892\/ijmm.2018.3687","article-title":"Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-\u03b1-induced expression of nitric oxide synthase in dorsal root ganglion neurons","volume":"42","author":"Tan","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cncr.32059","article-title":"The role of cancer in marijuana and prescription opioid use in the United States: a population-based analysis from 2005 to 2014","volume":"125","author":"Tringale","year":"2019","journal-title":"Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","article-title":"Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity","volume":"21","author":"van der Stelt","year":"2001","journal-title":"J. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pbb.2013.02.008","article-title":"Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy","volume":"105","author":"Vera","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B81","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","article-title":"Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice","volume":"113","author":"Ward","year":"2011","journal-title":"Anesth. Analg."},{"key":"B83","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1212\/wnl.44.3_part_1.488","article-title":"The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro","volume":"44","author":"Windebank","year":"1994","journal-title":"Neurology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejphar.2008.01.010","article-title":"Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain","volume":"583","author":"Yamamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zaj\u0105czkowska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/s1516-44462006000200015","article-title":"History of cannabis as a medicine: a review","volume":"28","author":"Zuardi","year":"2006","journal-title":"Rev. Bras. Psiquiatr."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1395951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:27:08Z","timestamp":1718166428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1395951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":86,"alternative-id":["10.3389\/fphar.2024.1395951"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1395951","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"article-number":"1395951"}}